NFE2L2 rs6721961: Understanding Your Genetic Variant
The rs6721961 variant is a single nucleotide polymorphism located in the promoter region of the NFE2L2 gene. It is associated with variations in gene expression that may influence how the body manages oxidative stress and responds to environmental factors.
What each genotype means
Common NRF2 promoter variant
This genotype represents the most frequently observed sequence at this promoter location in many populations. Research suggests this variant may influence how the NRF2 gene regulates the body's antioxidant response, though the functional impact can vary significantly depending on environmental factors like smoking or oxidative stress levels.
This is the most common genotype, observed in approximately 60% of individuals in some studied populations.
Heterozygous NRF2 promoter variant
Carrying one copy of the T allele alongside the C allele may modulate the expression of NRF2, a key regulator of the body's defense against oxidative stress. Some studies have explored associations between this genotype and susceptibility to certain inflammatory or oxidative conditions, but results are mixed and often depend on specific ancestry or environmental exposures.
This genotype is found in roughly 34% of individuals in some populations, though frequencies vary by ancestry.
Alternative NRF2 promoter variant
This genotype involves two copies of the T allele, which has been investigated for its potential role in altering NRF2-mediated gene expression. While some research links this variant to differences in oxidative stress management or disease risk, these findings are not universal and may be influenced by other genetic or lifestyle factors.
This is a less common genotype, appearing in approximately 6% of individuals in some studied groups.
Rare NRF2 promoter variant
This genotype involves the presence of the G allele, which is less frequently documented in literature compared to the C and T alleles. Research on this specific combination is limited, and its functional impact on NRF2 expression remains unclear.
This genotype is rare and its frequency is not well-established across global populations.
What is rs6721961?
The rs6721961 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located on chromosome 2 within the NFE2L2 gene. In genetics, a promoter variant like this sits in the regulatory region of a gene, which acts like a control switch. By residing in this area, rs6721961 has the potential to influence how much of the NFE2L2 protein is produced by your cells. Because this gene is a master regulator of cellular defense, even small changes in its expression levels can theoretically alter how your body handles internal and external stressors. Researchers study this SNP to understand why individuals might have different baseline capacities for managing oxidative damage, which occurs when there is an imbalance between free radicals and the body's ability to neutralize them.
The Role of the NFE2L2 Gene
The NFE2L2 gene provides instructions for making a protein called NRF2. This protein is often described as a 'master regulator' of the antioxidant response. Under normal conditions, NRF2 is kept at low levels in the cell by a protein called KEAP1, which marks it for degradation. However, when the cell experiences oxidative stress or encounters certain environmental toxins, this degradation process is inhibited. NRF2 then accumulates and moves into the cell nucleus, where it binds to specific DNA sequences known as antioxidant response elements (AREs). This binding triggers the expression of a wide array of cytoprotective genes, including those responsible for detoxification and the production of antioxidants. By coordinating this defense system, NRF2 helps protect cells from damage and maintains overall redox homeostasis.
Research Associations and Evidence
Scientific research has investigated rs6721961 for its potential links to various health conditions, though the evidence remains moderate and sometimes conflicting. Some studies have suggested that specific alleles of this SNP may be associated with an increased risk of developing type 2 diabetes or experiencing oxidative stress-related complications. Other research has explored its role in susceptibility to conditions like Parkinson's disease or its influence on lung function decline in smokers. It is important to note that these associations are often observed in specific populations and may not be universal. Furthermore, many studies are retrospective or preliminary, meaning they identify correlations rather than direct causation. Because the NFE2L2 pathway is complex and influenced by many other genetic and environmental factors, the clinical significance of this single variant is not yet fully established.
Population Frequency
The frequency of the rs6721961 variant varies significantly across different global populations. According to data from large-scale genomic databases, the minor allele frequency is approximately 0.15, though this can fluctuate depending on ancestral background. Because this variant is common, it is considered a normal part of human genetic diversity rather than a rare mutation.
What This Information Means for You
If you have received information about your rs6721961 genotype, it is helpful to view it as one small piece of a much larger biological puzzle. Genetic variants do not act in isolation; your health is shaped by a complex interplay between your DNA, your lifestyle, your diet, and your environment. While some research suggests this variant might influence how your body manages oxidative stress, there is no standardized medical test or treatment based solely on this SNP. You cannot use this information to diagnose a condition or predict your future health with certainty. If you are concerned about oxidative stress or your metabolic health, the most effective approach is to focus on evidence-based lifestyle choices, such as a balanced diet and regular exercise. Always consult with a qualified healthcare provider or a registered dietitian before making significant changes to your health regimen or starting any new supplements.
How common is this variant?
The rs6721961 variant is common, with a global minor allele frequency of approximately 0.15, though this frequency varies across different ancestral groups.
Frequently asked questions
Can I use this SNP to predict my risk of disease?
No. Genetic variants like rs6721961 are only one of many factors that influence health. They cannot be used to predict disease risk or provide a medical diagnosis.
Should I take supplements based on my NFE2L2 genotype?
There is no clinical evidence supporting the use of specific supplements based on this SNP. Always discuss any supplement use with your doctor or pharmacist to ensure it is safe for your individual health needs.
Is rs6721961 a 'bad' gene variant?
No. Genetic variants are simply variations in DNA sequence. Most variants, including this one, are part of normal human diversity and do not inherently represent a 'bad' or 'good' trait.
Where can I find more reliable information on NFE2L2?
You can find authoritative information on the NFE2L2 gene and its functions through resources like MedlinePlus Genetics, the NCBI Gene database, and the GWAS Catalog.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6721961?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NFE2L2
This SNP is located in the promoter region of the NRF2 gene and influences the expression levels of enzymes involved in the cellular antioxidant response.
NRF2 regulatory region variant influencing cytoprotective antioxidant response element transcription following cutaneous solar ultraviolet exposure.
This promoter regulatory variant in the NFE2L2 (NRF2) gene modulates antioxidant response pathway activity and has been associated in GWAS with cardiovascular risk and oxidative stress-related phenotypes.